The association of elevated serum lipocalin 2 levels with diabetic peripheral neuropathy in type 2 diabetes

A variety of studies have demonstrated the role of lipocalin 2 (LCN2) in both diabetes and neurological disorders. Nevertheless, the relationship between LCN2 and diabetic peripheral neuropathy (DPN) needs to be elucidated in humans. Therefore, this study aimed to investigate the association of LCN2...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xi Zhang, Xiurong Shen, Wan Zhou, Mengyun Xu, Yan Xing, Jianping Weng, Shandong Ye, Suowen Xu, Zhi Zhang, Wei Wang
Formato: article
Lenguaje:EN
Publicado: Bioscientifica 2021
Materias:
Acceso en línea:https://doi.org/10.1530/EC-21-0290
https://doaj.org/article/dfb71237b6034673b9425ca3c43a26fa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dfb71237b6034673b9425ca3c43a26fa
record_format dspace
spelling oai:doaj.org-article:dfb71237b6034673b9425ca3c43a26fa2021-11-10T08:22:45ZThe association of elevated serum lipocalin 2 levels with diabetic peripheral neuropathy in type 2 diabeteshttps://doi.org/10.1530/EC-21-02902049-3614https://doaj.org/article/dfb71237b6034673b9425ca3c43a26fa2021-11-01T00:00:00Zhttps://ec.bioscientifica.com/view/journals/ec/10/11/EC-21-0290.xmlhttps://doaj.org/toc/2049-3614A variety of studies have demonstrated the role of lipocalin 2 (LCN2) in both diabetes and neurological disorders. Nevertheless, the relationship between LCN2 and diabetic peripheral neuropathy (DPN) needs to be elucidated in humans. Therefore, this study aimed to investigate the association of LCN2 with DPN in type 2 diabetes (T2D). A total of 207 participants with T2D and 40 participants with normal glucose tolerance (NGT) were included in this study. All participants were classified in to DPN group and non-DPN (NDPN) group based on the Toronto Clinical Neuropathy Scoring (TCNS). Demographic and biochemical parameters were measured. Serum LCN2 levels wer e determined using an ELISA technique. Serum LCN2 levels in NGT group were lower t han those in either DPN group (P = 0.000) or NDPN group (P = 0.043), while serum LCN2 levels in DPN group were higher than NDPN group (P = 0.001). Moreover, serum LCN2 levels positively correlated to TCNS scores, which reflects neuropathy severity ( r = 0.438, P = 0.000). Multivariate stepwise regression analysis showed that BMI, triglycerides, an d diastolic pressure were independently associated with serum LCN2 in DPN. Additionally, logistic regression analysis demonstrated that LCN2 (odds ratio (OR) = 1.009) and diabetes duration (OR = 1.058) were independently associated with the occurrence of DP N in T2D. Our report reveals the association of serum LCN2 with DPN in T2D. LCN2 mig ht be used to evaluate DPN severity and serve a role in the pathogenesis of DPN.Xi ZhangXiurong ShenWan ZhouMengyun XuYan XingJianping WengShandong YeSuowen XuZhi ZhangWei WangBioscientificaarticlediabetic peripheral neuropathydiabetic complicationlipocalin 2type 2 diabetesDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENEndocrine Connections, Vol 10, Iss 11, Pp 1403-1409 (2021)
institution DOAJ
collection DOAJ
language EN
topic diabetic peripheral neuropathy
diabetic complication
lipocalin 2
type 2 diabetes
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
spellingShingle diabetic peripheral neuropathy
diabetic complication
lipocalin 2
type 2 diabetes
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Xi Zhang
Xiurong Shen
Wan Zhou
Mengyun Xu
Yan Xing
Jianping Weng
Shandong Ye
Suowen Xu
Zhi Zhang
Wei Wang
The association of elevated serum lipocalin 2 levels with diabetic peripheral neuropathy in type 2 diabetes
description A variety of studies have demonstrated the role of lipocalin 2 (LCN2) in both diabetes and neurological disorders. Nevertheless, the relationship between LCN2 and diabetic peripheral neuropathy (DPN) needs to be elucidated in humans. Therefore, this study aimed to investigate the association of LCN2 with DPN in type 2 diabetes (T2D). A total of 207 participants with T2D and 40 participants with normal glucose tolerance (NGT) were included in this study. All participants were classified in to DPN group and non-DPN (NDPN) group based on the Toronto Clinical Neuropathy Scoring (TCNS). Demographic and biochemical parameters were measured. Serum LCN2 levels wer e determined using an ELISA technique. Serum LCN2 levels in NGT group were lower t han those in either DPN group (P = 0.000) or NDPN group (P = 0.043), while serum LCN2 levels in DPN group were higher than NDPN group (P = 0.001). Moreover, serum LCN2 levels positively correlated to TCNS scores, which reflects neuropathy severity ( r = 0.438, P = 0.000). Multivariate stepwise regression analysis showed that BMI, triglycerides, an d diastolic pressure were independently associated with serum LCN2 in DPN. Additionally, logistic regression analysis demonstrated that LCN2 (odds ratio (OR) = 1.009) and diabetes duration (OR = 1.058) were independently associated with the occurrence of DP N in T2D. Our report reveals the association of serum LCN2 with DPN in T2D. LCN2 mig ht be used to evaluate DPN severity and serve a role in the pathogenesis of DPN.
format article
author Xi Zhang
Xiurong Shen
Wan Zhou
Mengyun Xu
Yan Xing
Jianping Weng
Shandong Ye
Suowen Xu
Zhi Zhang
Wei Wang
author_facet Xi Zhang
Xiurong Shen
Wan Zhou
Mengyun Xu
Yan Xing
Jianping Weng
Shandong Ye
Suowen Xu
Zhi Zhang
Wei Wang
author_sort Xi Zhang
title The association of elevated serum lipocalin 2 levels with diabetic peripheral neuropathy in type 2 diabetes
title_short The association of elevated serum lipocalin 2 levels with diabetic peripheral neuropathy in type 2 diabetes
title_full The association of elevated serum lipocalin 2 levels with diabetic peripheral neuropathy in type 2 diabetes
title_fullStr The association of elevated serum lipocalin 2 levels with diabetic peripheral neuropathy in type 2 diabetes
title_full_unstemmed The association of elevated serum lipocalin 2 levels with diabetic peripheral neuropathy in type 2 diabetes
title_sort association of elevated serum lipocalin 2 levels with diabetic peripheral neuropathy in type 2 diabetes
publisher Bioscientifica
publishDate 2021
url https://doi.org/10.1530/EC-21-0290
https://doaj.org/article/dfb71237b6034673b9425ca3c43a26fa
work_keys_str_mv AT xizhang theassociationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT xiurongshen theassociationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT wanzhou theassociationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT mengyunxu theassociationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT yanxing theassociationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT jianpingweng theassociationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT shandongye theassociationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT suowenxu theassociationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT zhizhang theassociationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT weiwang theassociationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT xizhang associationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT xiurongshen associationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT wanzhou associationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT mengyunxu associationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT yanxing associationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT jianpingweng associationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT shandongye associationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT suowenxu associationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT zhizhang associationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
AT weiwang associationofelevatedserumlipocalin2levelswithdiabeticperipheralneuropathyintype2diabetes
_version_ 1718440422974423040